Skip to main content
Premium Trial:

Request an Annual Quote

Harvard Bio Q3 Revenues Rise

NEW YORK, Oct. 29 (GenomeWeb News) - Harvard Bioscience, the parent company of Genomic Solutions, late yesterday reported increased revenues for the third quarter.


The company's revenues for the quarter came to $21.1 million, up from $12.8 million for the third quarter of 2002. Net income was $986,000, compared to an $82,000 loss for the same period last year.


"[I]t is primarily the impact of the new products we have added through the acquisitions of Genomic Solutions, BTX, GeneMachines and most recently, BioRobotics that were the major contributors to our success for the quarter," Harvard Bioscience CEO Chane Graziano said in a statement.


R&D expenses totaled $1.6 million, up from $1 million for the same period last year.


At the end of the quarter the company had $7.6 million in cash and cash equivalents, compared with $15.3 million as of December 31, 2002.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.